Gangliosides expressed in human breast cancer

Cancer Research

Volumn 56, Issue 22, 1996, Pages 5165-5171

  Marquina, Gilda ^a,b   Waki, Hatsue ^a   Fernandez, Luis E ^b   Kon, Kazuo ^a   Carr, Adriana ^b   Valiente, Oscar ^b   Perez, Rolando ^b   Ando, Susumu ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b CENTER OF MOLECULAR IMMUNOLOGY   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; CANCER VACCINE; GANGLIOSIDE GD3; GANGLIOSIDE GM3; N GLYCOLOYLNEURAMINIC ACID; SIALIC ACID;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MASS SPECTROMETRY; PRIORITY JOURNAL;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; GANGLIOSIDES; HUMANS; NEOPLASM PROTEINS; NEURAMINIC ACIDS;

EID: 0029803151     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Hakomori, S-I. Aberrant glycosylation in cancer cell membranes as focused on glycolipids overview and perspectives. Cancer Res., 45: 2405-2414, 1985.
2. Hakomori, S-I Role of gangliosides in transmembrane signaling and cell recognition. In: A. Rosenberg (ed.), Biology of the Stalic Acids, pp 243-256. New York. Plenum Press, 1995
3. Cheresh, D. A., Varki, A. P., Varki, N. M., Stallcup, W. B, Levine, J, and Reisfeld, R. A. A monoclonal antibody recognizes an O-acetylated sialic acid in a human melanoma-associated ganglioside. J. Biol. Chem., 259: 7453-7459, 1984
4. Carubia, J. M., Yu, R K, Macala, L. J, Kirkwood, J M., and Varga, J. M. Gangliosides of normal and neoplastic human melanocytes Biochem. Biophys. Res. Commun., 120: 500-504, 1984
5. Tsuchida, T., Saxton, R. E, Morton, D. L, and Irie, R. F. Gangliosides of human melanoma. Cancer (Phila.). 63: 1166-1174, 1989.
6. Ravindranath, M. H., Tsuchida, T., Morton, D. L, and Irie, R. F Ganglioside GM3,GD3 ratio as an index for the management of melanoma Cancer (Phila), 67: 3029-3035, 1991
7. Hamilton, W. B., Helling, F., Lloyd, K. O., and Livingston, P. O. Ganglioside expression on human malignant melanoma assessed by quantitative immune trin-layer chromatography Int. J Cancer, 53: 566-573, 1993.
8. Higashi, H , Hirabayashi, Y., Fukui, Y., Naiki, M., Matsumoto, M., Ueda, S, and Kato, S. Characterization of N-glycolylneuraminic acid-containing gangliosides as tumor-associated Hanganutziu-Deicher antigen in human colon cancer Cancer Res., 45: 3796-3802, 1985
9. Dohi, T., Ohta, S. Hanai, N, Yamaguchi, K, and Oshima, M. Sialylpentaosylceramide detected with anti-GM2 monoclonal antibody. Structural characterization and complementary expression with GM2 in gastric cancer and normal gastric mucosa. J. Biol. Chem . 265: 7880-7885, 1990.
10. Ogata, S., Ho, I., Chen, A, Dubois, D, Maklansky, J., Singhal, A, Hakomori, S-I, and Itzkowitz, S. H Tumor-associated sialylated antigens are constitutively expressed in normal human colonie mucosa Cancer Res., 55: 1869-1874, 1995.
11. Nilsson, O, Brezicka, F T., Holmgren, J., Sorenson, S., Svennerholm, L., Yngvason, F., and Lindholm, L. Detection of a ganglioside antigen associated with small cell lung carcinomas using monoclonal antibodies directed against fucosyl-GM1. Cancer Res., 46: 1403-1407, 1989.
12. Brezicka, F-T., Olling, S., Nilsson, O., Bergh, J., Holmgren, J, Sorenson, S., Yngvason, F., and Lindholm, L. Immunohistological detection of fucosyl-GM1 ganslioside in human lung cancer and normal tissues with monoclonal antibodies. Cancer Res., 49: 1300-1305, 1989
13. Murayama, K., Levery, S B, Schirrmacher, V, and Hakomori, S-I. Quantitative differences in position of sialylation and surface expression of glycolipid between murine lymphomas with low metastatic (Eb) and high metastatic (ESb) potentials and isolation of a novel disialoganglioside (GD1α) from Eb cells. Cancer Res., 46: 1395-1402, 1986
14. Schulz, G., Cheresh, D. A, Varki, N. M., Yu, A., Staffileno, L. K., and Reisfeld, R. A. Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients. Cancer Res., 44: 5914-5920, 1984.
15. Saito, M., Yu, R K., and Cheung, N-K. V Ganglioside GD2 specificity of monoclonal antibodies to human neuroblastoma cell Biochem Biophys Res. Commun, 127: 1-7, 1985.
16. Wu, Z-L., Schwartz, E, Seeger, R, and Ladisch, S Expression of GD2 ganglioside by untreated primary human neuroblastomas. Cancer Res., 46: 440-443, 1986.
17. Ye, J. N., and Cheung, N-K V. A novel O-acetylated ganglioside detected by anti-GD2 monoclonal antibodies. Int J. Cancer, 50: 197-201, 1992
18. Dyatlovitskaya, E V., Tekieva, E. A., Lemenovskaya, A. F., Somova, O G., and Bergelson, L D. Gangliosides GM3 and GD3 in human gastric and mammary tumors. Biokyimiya, 56: 560-564, 1991.
19. Wiesner, D. A., and Sweely, C. C. Circulating gangliosides of breast-cancer patients. Int. J. Cancer, 60: 294-299, 1995.
20. Waki, H., Kon, K., Tanaka, Y, and Ando, S. Facile methods for isolation and determination of gangliosides in small scale. age-related changes of gangliosides in mouse brain synaptic plasma membranes. Anal. Biochem, 222: 156-162, 1994.
21. Ando, S Chang, N-C., and Yu, R K High-performance thin-layer chromatography and densitometric determination of brain ganglioside compositions of several species. Anal Biochem, 89: 437-450, 1978.
22. Svennerholm, L Chromatographic separation of human brain gangliosides. J Neurochem., 10: 613-623, 1963
23. Saito, M., Kasai, N., and Yu, R K. In situ immunological determination of basic carbohydrate structures of gangliosides on thin-layer plates. Anal. Biochem., 148: 54-58, 1985.
24. Ozawa, H. Kotani, M, Kawashima, I., and Tai, T. Generation of one set of monoclonal antibodies specific for b-pathway ganglio-series gangliosides. Biochem Biophys Acta, 1123: 184-190, 1992
25. Higashi, H., and Naiki, M. Antigen of "serum sickness" type of heterophile antibodies in human sera: identification as gangliosides with N-glycolylneuraminic acid. Biochem. Biophys Res. Commun., 79: 388-395, 1977
26. Fujii, Y., Higashi, H, Ikuta, K, Kato, S., and Naiki, M. Specifities of human heterophilic Hanganutziu and Deicher (H-D) antibodies and avian antisera against H-D antigen-active glycosphingohpids. Mol Immunol., 19, 87-94, 1982
27. Vazquez, A. M., Alfonso, M, Lanne, B, Karlsson, K-A, Carr, A., Barroso, O., Fernandez, L. E, Rengifo, M. E., Lanio, M. E., Alvarez, C, Zeuthen, J. and Perez, R Generation of a murine monoclonal antibody specific for N-glycolylneuraminic acid-containing gangliosides which also recognizes sulfated glycolipids. Hybridoma. 13: 551-556, 1995
28. Waki, H., Murata, A, Kon, K., Maruyama, K., Kimura, S, Ogura, H., and Ando, S, Isolation and characterization of a trisialyllactosylceramide, GT3, containing an O-acetylated sialic acid in cod fish brain. J Biochem, 113: 502-507, 1993.
29. Hirabayashi, Y., Nakao, T., and Matsumoto, M. Improved method for large-scale purification of brain gangliosides by Q-Sepharose column chromatography J. Chromatogr., 445: 377-384, 1988.
30. Kawai, T , Kato, A, Higashi, H., Kato, S, and Naiki, M. Quantitative determination of N-glycolylneuraminic acid expression in human cancerous tissues and avian lymphoma cell lines as a tumor-associated sialic acid by gas chromatography-mass spectrometry. Cancer Res, 51: 1242-1246, 1991
31. Merritt, W. D, Richardson, C. L., Keenan, T. W, and Morré, D J Ganglioside of liver tumors induced by N-fluorenylacetamide. 1 Ganglioside alterations in liver tumorigenesis and normal development. J Natl Cancer Inst., 60: 1313-1325, 1978.
32. Kloppel, T. M, and Morré, D. J. Characteristics of transplantable tumors induced in the rat by N-2-fluorenylacetamide: elevation in tissue and serum sialic acid. J. Natl. Cancer Inst, 64: 1401-1409, 1980.
33. Zheng, M., Fang, H., Tsuruoka, T., Tsuji, T., Sasaki, T, and Hakomori, S-I. Regulatory role of GM3 ganglioside in α5β1 integrin receptor for fibronectin-mediated adhesion of FUA169 cells. J. Biol. Chem., 268: 2217-2222, 1993
34. Cheresh, D A, Pytela, R, Pierschbacher, M. D., Klier, F. G, Ruoslahti, E., and Reisfeld, R A An Arg-Gly-Asp-directed receptor on the surface of human melanoma cells exists in a divalent cation-dependent functional complex with the disialoganglioside GD2. J. Cell Biol., 105: 1163-1173, 1987.
35. Thurin, J., Herlyn, M., Hindsgaul, O., Stromberg, N., Karlsson, K-A, Elder, D., Steplewski, Z., and Koprowski, H. Proton NMR and fast-atom bombardment mass spectrometry analysis of the melanoma-associated ganglioside 9-O-acetyl-GD3, J. Biol. Chem , 260: 14556-14563, 1985.
36. Ren, S., Scarsdale, J. N, Ariga, T, Zhang, Y., Klein, R A, Hartmann, R, Kushi, Y, Egge, H, and Yu, R K. O-Acetylated gangliosides in bovine buttermilk. J. Biol. Chem., 267: 12632-12638, 1992.
37. Mendez-Otero, R., Schlosshauer, B., Barnstable, C. J., and Constantine-Paton, M. A developmentally regulated antigen associated with neural cell and process migration. J Neurosci., 8: 564-579, 1988.
38. Hirabayashi, Y., Hirota, M , Suzuki, Y., Matsumoto, M., Obata, K., and Ando, S. Developmentally expressed O-acelyl ganglioside GT3 in fetal rat cerebral cortex. Neurosci. Lett., 106: 193-198, 1989.
39. Igarashi, M, Waki, H, Saito, S., Komiya, Y., and Ando, S. Characteristics of gangliosides including O-acetylated species in growth cone membranes at several developmental stages in rat forebrain. Dev. Brain Res., 78: 17-24, 1994.
40. Nakarai, H., Chandler, P. J., Kano, K., Morton, D L., and Irie, R. F. Hanganutziu-Deicher antigen as a possible target for immunotherapy of melanoma. Int. Arch Allergy Appl. Immunol., 91: 323-328, 1990
41. Miyake, M, Hashimoto, K., Ito, M., Ogawa, O., Arai, E., Hitomi, S., and Kannagi, R. The abnormal occurrence and the differentiation-dependent distribution of N-acetyl and N-glycolyl species of the ganglioside GM2 in human germ cell tumors. Cancer (Phila.), 65: 499-505, 1990